Qiagen NV (QGEN)
Healthcare
Diagnostics & Research
41.40 $
-0.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Qiagen NV (QGEN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.3% of the shares are freely tradable; institutional investors hold 83.0%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
83.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
99.3%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
4.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
206Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Wellington Management Company LLP | 6.96 | 14,364,303 | +6.9 | 03/31/2026 |
| T. Rowe Price Associates, Inc. | 4.09 | 8,429,334 | +5.3 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.96 | 6,106,275 | +0.0 | 03/31/2026 |
| Deutsche Bank AG | 2.72 | 5,601,957 | -25.4 | 03/31/2026 |
| BlackRock Inc | 2.55 | 5,250,461 | +2.3 | 03/31/2026 |
| Amundi | 2.31 | 4,757,681 | +18.3 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Health Care Inv | 3.16 | 6,514,443 | +0.0 | 06/30/2026 |
| T. Rowe Price International Gr Eq Tr-D | 2.61 | 5,376,369 | +32.0 | 06/30/2026 |
| MFS International Equity | 2.12 | 4,363,511 | -5.4 | 06/30/2026 |
| MFS International Equity R6 | 2.12 | 4,363,511 | -2.1 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.